Diphenylterazine free base
Diphenylterazine (DTZ) is a bioluminescence agent.
For research use only. Not for human or veterinary use.
Diphenylterazine structure
CAS No.: 344940-63-2
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 50 mg | USD 420.00 | BP-02205-50mg | In stock | Get quote |
| 100 mg | USD 670.00 | BP-02205-100mg | In stock | Get quote |
| 250 mg | USD 1,340.00 | BP-02205-250mg | In stock | Get quote |
| 500 mg | USD 2,150.00 | BP-02205-500mg | In stock | Get quote |
| 1 g | USD 3,440.00 | BP-02205-1g | In stock | Get quote |
Need another size or custom synthesis? Request a quote.
Description
Diphenylterazine (DTZ) is a bioluminescence agent. Diphenylterazine alone yielded very little background, leading to excellent signal-to-background ratios[1].
Biological activity
n Vitro Diphenylterazine elicits minimal cell toxicity at millimolar concentrations. Diphenylterazine (DTZ) has high quantum yield, red-shifted emission, favorable in vivo pharmacokinetics and lacks cofactors required for light emission. Yeh AH (2023) used Diphenylterazine (DTZ) as the target substrate of luciferase, and the multinuclear transport factor NTF2-like superfamily as the target topology, to de novo design a small and stable protein scaffold to make the size and shape of the pocket suitable for Diphenylterazine. This method screens out designed luciferases with high selectivity and overcomes the limitations of natural proteins. The catalytic efficiency of the de novo designed luciferase for Diphenylterazine (kcat/Km = 106/M/s) is comparable to that of natural luciferase, but the substrate specificity is higher. Notes: To make a stock solution for DTZ (Diphenylterazine), first, a premixture is prepared by dissolving 17.6 mg of L-ascorbic acid (HY-B0166) in 10 mL ethanol and 10 mL 1,2-propanediol; next, 1 mg of Diphenylterazine is dissolved in 88 μL of the premix, resulting in a 30 mM Diphenylterazine stock solution containing 5 mM L-ascorbic acid. The stock solution should be stable for a few months in -80°C freezers. It may also be aliquoted to 10-20 μL each at -80°C for the convenience of use. We want to note that this new formulation greatly enhances substrate stability, compared to the conventional acidic alcohol solution. In Vivo Diphenylterazine injections into untransfected BALB/c mice do not yield any background emission. The bioluminescence resulting from intraperitoneally injected Diphenylterazine displays extended kinetics. 1. Female nude mice were injected subcutaneously with HeLa cells. 2. Diphenylterazine (0.3 μmol (0.113 mg); 100 μL) was injected intravenously on days 1, 3, 5, 7, 14, and 28 after tumor implantation. 3. Approximately 5 minutes later, images were taken using a bioluminescence imaging system.
Identifiers
- SMILES
-
O=C1C(CC2=CC=CC=C2)=NC3=C(C4=CC=CC=C4)NC(C5=CC=CC=C5)=CN31 - InChIKey
-
HYQVAZNNCBIZSK-UHFFFAOYSA-N
Specifications
- MW (average)
- 377.4379
- Formula
- C25H19N3O
- CAS No.
- 344940-63-2
- Physical state
- Solid
- Color
- Orange to reddish brown
- Shipping
- Shipping with dry ice.
- Storage
- -80°C, protect from light, stored under nitrogen
Solubility
soluble in H2O/DMF
Documents
References
Same target
Search Fluorescent DyeSame research area
Search Cancer- BP-00084 ORIC-944 free base · >98%
- BP-00104 BMS-986397 free base · >98%
- BP-00343 Opadotin free base · >98%
- BP-00752 CR-1-31-B free base · >98%
- BP-00756 PF-07853578 free base · >98%
- BP-00771A dTAGV-1 hydrochloride salt · >98%
- BP-00882 OPB-171775 free base · HPLC >98%, ee>98%
- BP-00998 BGB-116673 analog free base · >98%